# Nomadar Corp.: financial statements, quarterly

NOMA · Nasdaq · CIK 1994214 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/noma.md) · [Financials](/companies/noma/financials.md) · [Filings](/companies/noma/filings.md) · [Insiders](/companies/noma/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/noma/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | [187](/filings/0001493152-26-023746.md) | [313](/filings/0001493152-26-038330.md) | [378](/filings/0001493152-25-024710.md) | [44.3 d](/filings/0001493152-26-014229.md) | [404](/filings/0001493152-26-023746.md) | [670](/filings/0001493152-26-038330.md) |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | [176](/filings/0001493152-26-023746.md) | [94.7](/filings/0001493152-26-038330.md) | [72.6](/filings/0001493152-25-024710.md) | [101 d](/filings/0001493152-26-014229.md) | [47.9](/filings/0001493152-26-023746.md) | [70.5](/filings/0001493152-26-038330.md) |
| Gross profit | $k | not reported | not reported | not reported | not reported | [10.5](/filings/0001493152-26-023746.md) | [218](/filings/0001493152-26-038330.md) | [306](/filings/0001493152-25-024710.md) | [(56.9) d](/filings/0001493152-26-014229.md) | [356](/filings/0001493152-26-023746.md) | [599](/filings/0001493152-26-038330.md) |
| Operating income | $k | not reported | not reported | [(498)](/filings/0001493152-25-024710.md) | [(484) d](/filings/0001493152-26-014229.md) | [(286)](/filings/0001493152-26-023746.md) | [(229)](/filings/0001493152-26-038330.md) | [(292)](/filings/0001493152-25-024710.md) | [(1,884) d](/filings/0001493152-26-014229.md) | [(779)](/filings/0001493152-26-023746.md) | [(224)](/filings/0001493152-26-038330.md) |
| Interest expense | $k | not reported | not reported | [1.9](/filings/0001493152-25-024710.md) | not reported | [5.0](/filings/0001493152-26-023746.md) | [7.5](/filings/0001493152-26-038330.md) | [22.3](/filings/0001493152-25-024710.md) | [57.9 d](/filings/0001493152-26-014229.md) | [3.1](/filings/0001493152-26-023746.md) | [23.5](/filings/0001493152-26-038330.md) |
| Net income | $k | [(110)](/filings/0001493152-25-024710.md) | [(275)](/filings/0001493152-25-024710.md) | [(500)](/filings/0001493152-25-024710.md) | [(488) d](/filings/0001493152-26-014229.md) | [(291)](/filings/0001493152-26-038330.md) | [(623)](/filings/0001493152-26-038330.md) | [(496)](/filings/0001493152-25-024710.md) | [(1,357) d](/filings/0001493152-26-014229.md) | [(1,587)](/filings/0001493152-26-038330.md) | [(440)](/filings/0001493152-26-038330.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.03)](/filings/0001493152-25-024710.md) | not reported | [(0.03)](/filings/0001493152-26-023746.md) | [(0.04)](/filings/0001493152-26-038330.md) | [(0.03)](/filings/0001493152-25-024710.md) | not reported | [(0.10)](/filings/0001493152-26-023746.md) | [(0.03)](/filings/0001493152-26-038330.md) |
| Basic EPS | $ per share | not reported | not reported | [(0.03)](/filings/0001493152-25-024710.md) | not reported | [(0.03)](/filings/0001493152-26-023746.md) | [(0.04)](/filings/0001493152-26-038330.md) | [(0.03)](/filings/0001493152-25-024710.md) | not reported | [(0.10)](/filings/0001493152-26-023746.md) | [(0.03)](/filings/0001493152-26-038330.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-014229.md) | not reported | not reported | [0.1](/filings/0001493152-25-024710.md) | [0.1](/filings/0001493152-26-038330.md) | [2.0](/filings/0001493152-26-023746.md) | [0.4](/filings/0001493152-26-038330.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-014229.md) | not reported | not reported | [0.3](/filings/0001493152-25-024710.md) | [0.3](/filings/0001493152-26-038330.md) | [2.7](/filings/0001493152-26-023746.md) | [5.8](/filings/0001493152-26-038330.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-014229.md) | not reported | not reported | [10.5](/filings/0001493152-25-024710.md) | [14.1](/filings/0001493152-26-038330.md) | [19.1](/filings/0001493152-26-023746.md) | [18.8](/filings/0001493152-26-038330.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [0.9](/filings/0001493152-26-014229.md) | not reported | not reported | [4.5](/filings/0001493152-25-024710.md) | [4.2](/filings/0001493152-26-038330.md) | [7.4](/filings/0001493152-26-023746.md) | [5.1](/filings/0001493152-26-038330.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [1.4](/filings/0001493152-26-014229.md) | not reported | not reported | [5.1](/filings/0001493152-25-024710.md) | [6.9](/filings/0001493152-26-038330.md) | [7.4](/filings/0001493152-26-023746.md) | [5.1](/filings/0001493152-26-038330.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [0.5](/filings/0001493152-26-014229.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(0.0)](/filings/0001493152-26-014229.md) | [(0.1)](/filings/0001493152-25-024710.md) | [(0.4)](/filings/0001493152-25-024710.md) | [(0.9)](/filings/0001493152-25-024710.md) | [(1.4)](/filings/0001493152-26-038330.md) | [(1.7)](/filings/0001493152-26-038330.md) | [5.9](/filings/0001493152-26-038330.md) | [5.4](/filings/0001493152-25-024710.md) | [7.2](/filings/0001493152-26-038330.md) | [11.7](/filings/0001493152-26-038330.md) | [13.7](/filings/0001493152-26-038330.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(314) d](/filings/0001493152-26-014229.md) | [47.6](/filings/0001493152-26-023746.md) | [6.4 d](/filings/0001493152-26-038330.md) | [(1,555) d](/filings/0001493152-25-024710.md) | [564 d](/filings/0001493152-26-014229.md) | [(181)](/filings/0001493152-26-023746.md) | [(576) d](/filings/0001493152-26-038330.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | [2.9](/filings/0001493152-26-023746.md) | [1.1 d](/filings/0001493152-26-038330.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.1](/filings/0001493152-25-024710.md) | [14.1](/filings/0001493152-26-038330.md) | [14.9](/filings/0001493152-25-024710.md) | [17.0](/filings/0001493152-26-038330.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,283,529 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038330.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.